I.ve worked in two areas of research for NIH, and SPNS. so I know a little about the process of clinical trials, and the process of assessing patients that meet criteria to be accepted. I have a patient who has bee through the traditional therapy of Ribovirin and Pegasys, and was not able to complete the entire 26 week proably 22 or 23 weeks. At any rate he did have possitive viral load after a time after treatment. My question is, if he is a healthy person with no other chronic illnesses other than the hepatits c would that be a consideration for trials? Second question is are they at multicenter trials yet? Third question is the sites where they are being conducted? Fourth
what is the duration of the course of treatment? Last, when will the drug be available to the public? I saw a mention of the success of your drug on Fox Business today. Oh, one more question what if any side effects are associated
with treatment?
I look forward to your reply,
Thank you,
Charlotte Smith RN